Christine Holtz
Adult Health · Spring Grove, PANPI 1093146540
Payments from drug & device makers
Across 376 payments — averaging $16.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$1K
- AstraZeneca$620
- GSK$479
- Pfizer$361
- Lilly USA, LLC$330
- plus $2K from 27 others
What the payments were for
- Food & beverage$6,222100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 80 | $1,266 |
| Novo Nordisk | 94 | $1,244 |
| AstraZeneca | 35 | $620 |
| GSK | 28 | $479 |
| Pfizer | 27 | $361 |
| Lilly USA, LLC | 16 | $330 |
| Exact Sciences | 9 | $230 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $189 |
| Bayer | 7 | $139 |
| Boehringer Ingelheim | 9 | $138 |
| Otsuka America Pharmaceutical, Inc. | 7 | $132 |
| Teva Pharmaceuticals USA, Inc. | 6 | $129 |
| Merck | 5 | $113 |
| E.r. Squibb & Sons, L.L.C. | 3 | $111 |
| Amgen | 5 | $93 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $92 |
| Phathom Pharmaceuticals, Inc. | 4 | $81 |
| Novartis | 5 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $64 |
| Sanofi Pasteur Inc. | 3 | $51 |
| Xeris Pharmaceuticals, Inc. | 2 | $39 |
| Abbott | 2 | $38 |
| Sunovion Pharmaceuticals Inc. | 1 | $25 |
| Biogen | 1 | $24 |
| Boston Scientific | 1 | $23 |
| Solventum Corporation | 1 | $22 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Corium, LLC | 1 | $18 |
| Johnson & Johnson | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Dexcom, Inc. | 1 | $12 |
How this compares
$6,222 in reported general payments places this provider in the 90th percentile of 899 adult health providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 94 | $86,897 |
| OzempicSemaglutide | 60 | $66,101 |
| JardianceEmpagliflozin | 62 | $52,892 |
| FarxigaDapagliflozin Propanediol | 52 | $49,532 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 25 | $29,085 |
| TrulicityDulaglutide | 11 | $28,627 |
| MounjaroTirzepatide | 29 | $28,579 |
| Tresiba Flextouch U-100Insulin Degludec | 25 | $19,394 |
| RybelsusSemaglutide | 11 | $9,892 |
| CystadaneBetaine | 11 | $9,278 |
| Spiriva RespimatTiotropium Bromide | 12 | $6,822 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 11 | $5,345 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 11 | $5,055 |
| Advair HfaFluticasone Propion/Salmeterol | 11 | $2,781 |
| Memantine Hcl | 33 | $2,770 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $361 | $86,89794 claims |
| Novo NordiskOzempic, Rybelsus | $1,244 | $75,99371 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat, Stiolto Respimat | $138 | $64,76885 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $330 | $57,20640 claims |
| AstraZenecaFarxiga | $620 | $49,53252 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $479 | $34,43136 claims |
| AbbVieSynthroid | $1,266 | $2,38134 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 899 adult health providers in Pennsylvania.
Other adult health in Spring Grove
- Beth SandyPhiladelphia$924K
- Diane NewmanPhiladelphia$413K
- Jennifer MondilloSchwenksville$396K
- Elizabeth FaustDouglassville$356K
- Abigail SmithPhiladelphia$302K
- Jean CainAllentown$214K
- Lauren MassimoPhiladelphia$139K
- Jennifer KeeleyWexford$97K
- Debra EvansFarrell$85K
- Bethann MallonBlue Bell$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.